The Histone Variant MacroH2A1.2 Is Necessary for the Activation of Muscle Enhancers and Recruitment of the Transcription Factor Pbx1

Cell Reports

Volumn 14, Issue 5, 2016, Pages 1156-1168

  Dell'Orso, Stefania ^a   Wang, A Hongjun ^a   Shih, Han Yu ^a   Saso, Kayoko ^a   Berghella, Libera ^b   Gutierrez Cruz, Gustavo ^a   Ladurner, Andreas G ^c   O'Shea, John J ^a   Sartorelli, Vittorio ^a   Zare, Hossein ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; HISTONE H3; HISTONE VARIANT MACROH2A1.2; TRANSCRIPTION FACTOR PBX1; UNCLASSIFIED DRUG; CHROMATIN; HOMEODOMAIN PROTEIN; MACROH2A HISTONE; MYOD PROTEIN; PBX1 PROTEIN, MOUSE; PROTEIN BINDING; TRANSCRIPTION FACTOR; TRANSCRIPTOME;

ARTICLE; CELL ASSAY; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; MUSCLE CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SENSITIVITY ANALYSIS; SKELETAL MUSCLE; ACETYLATION; ANIMAL; CHROMATIN; CYTOLOGY; ENHANCER REGION; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; GENOME; HEK293 CELL LINE; METABOLISM; MOUSE; MUSCLE DEVELOPMENT;

ACETYLATION; ANIMALS; CELL DIFFERENTIATION; CHROMATIN; ENHANCER ELEMENTS, GENETIC; EPIGENESIS, GENETIC; GENE REGULATORY NETWORKS; GENOME; HEK293 CELLS; HISTONES; HOMEODOMAIN PROTEINS; HUMANS; MICE; MUSCLE CELLS; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MYOD PROTEIN; PROTEIN BINDING; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTOME;

EID: 84958019644     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.12.103     Document Type: Article

References (71)

1. Barrero M.J., Sese B., Kuebler B., Bilic J., Boue S., Martí M., Izpisua Belmonte J.C. Macrohistone variants preserve cell identity by preventing the gain of H3K4me2 during reprogramming to pluripotency. Cell Rep. 2013, 3:1005-1011.
2. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., Wang Z., Wei G., Chepelev I., Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837.
3. Bell O., Tiwari V.K., Thomä N.H., Schübeler D. Determinants and dynamics of genome accessibility. Nat. Rev. Genet. 2011, 12:554-564.
4. Benezra R., Davis R.L., Lockshon D., Turner D.L., Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 1990, 61:49-59.
5. Bergstrom D.A., Tapscott S.J. Molecular distinction between specification and differentiation in the myogenic basic helix-loop-helix transcription factor family. Mol. Cell. Biol. 2001, 21:2404-2412.
6. Berkes C.A., Bergstrom D.A., Penn B.H., Seaver K.J., Knoepfler P.S., Tapscott S.J. Pbx marks genes for activation by MyoD indicating a role for a homeodomain protein in establishing myogenic potential. Mol. Cell 2004, 14:465-477.
7. Bernstein E., Muratore-Schroeder T.L., Diaz R.L., Chow J.C., Changolkar L.N., Shabanowitz J., Heard E., Pehrson J.R., Hunt D.F., Allis C.D. A phosphorylated subpopulation of the histone variant macroH2A1 is excluded from the inactive X chromosome and enriched during mitosis. Proc. Natl. Acad. Sci. USA 2008, 105:1533-1538.
8. Bonn S., Zinzen R.P., Girardot C., Gustafson E.H., Perez-Gonzalez A., Delhomme N., Ghavi-Helm Y., Wilczyński B., Riddell A., Furlong E.E. Tissue-specific analysis of chromatin state identifies temporal signatures of enhancer activity during embryonic development. Nat. Genet. 2012, 44:148-156.
9. Buenrostro J.D., Giresi P.G., Zaba L.C., Chang H.Y., Greenleaf W.J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 2013, 10:1213-1218.
10. Buschbeck M., Uribesalgo I., Wibowo I., Rué P., Martin D., Gutierrez A., Morey L., Guigó R., López-Schier H., Di Croce L. The histone variant macroH2A is an epigenetic regulator of key developmental genes. Nat. Struct. Mol. Biol. 2009, 16:1074-1079.
11. Chakravarthy S., Luger K. The histone variant macro-H2A preferentially forms "hybrid nucleosomes". J. Biol. Chem. 2006, 281:25522-25531.
12. Chakravarthy S., Gundimella S.K., Caron C., Perche P.Y., Pehrson J.R., Khochbin S., Luger K. Structural characterization of the histone variant macroH2A. Mol. Cell. Biol. 2005, 25:7616-7624.
13. Chen H., Ruiz P.D., Novikov L., Casill A.D., Park J.W., Gamble M.J. MacroH2A1.1 and PARP-1 cooperate to regulate transcription by promoting CBP-mediated H2B acetylation. Nat. Struct. Mol. Biol. 2014, 21:981-989.
14. Cirillo L.A., Zaret K.S. An early developmental transcription factor complex that is more stable on nucleosome core particles than on free DNA. Mol. Cell 1999, 4:961-969.
15. Cirillo L.A., Lin F.R., Cuesta I., Friedman D., Jarnik M., Zaret K.S. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol. Cell 2002, 9:279-289.
16. Clark K.L., Halay E.D., Lai E., Burley S.K. Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 1993, 364:412-420.
17. Costanzi C., Pehrson J.R. Histone macroH2A1 is concentrated in the inactive X chromosome of female mammals. Nature 1998, 393:599-601.
18. Costanzi C., Pehrson J.R. MACROH2A2, a new member of the MARCOH2A core histone family. J. Biol. Chem. 2001, 276:21776-21784.
19. Creppe C., Janich P., Cantariño N., Noguera M., Valero V., Musulén E., Douet J., Posavec M., Martín-Caballero J., Sumoy L., et al. MacroH2A1 regulates the balance between self-renewal and differentiation commitment in embryonic and adult stem cells. Mol. Cell. Biol. 2012, 32:1442-1452.
20. Creyghton M.P., Cheng A.W., Welstead G.G., Kooistra T., Carey B.W., Steine E.J., Hanna J., Lodato M.A., Frampton G.M., Sharp P.A., et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. USA 2010, 107:21931-21936.
21. Csankovszki G., Nagy A., Jaenisch R. Synergism of Xist RNA, DNA methylation, and histone hypoacetylation in maintaining X chromosome inactivation. J. Cell Biol. 2001, 153:773-784.
22. Davis R.L., Weintraub H., Lassar A.B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987, 51:987-1000.
23. de la Serna I.L., Ohkawa Y., Berkes C.A., Bergstrom D.A., Dacwag C.S., Tapscott S.J., Imbalzano A.N. MyoD targets chromatin remodeling complexes to the myogenin locus prior to forming a stable DNA-bound complex. Mol. Cell. Biol. 2005, 25:3997-4009.
24. Doyen C.M., An W., Angelov D., Bondarenko V., Mietton F., Studitsky V.M., Hamiche A., Roeder R.G., Bouvet P., Dimitrov S. Mechanism of polymerase II transcription repression by the histone variant macroH2A. Mol. Cell. Biol. 2006, 26:1156-1164.
25. Feng J., Liu T., Qin B., Zhang Y., Liu X.S. Identifying ChIP-seq enrichment using MACS. Nat. Protoc. 2012, 7:1728-1740.
26. Fong A.P., Yao Z., Zhong J.W., Johnson N.M., Farr G.H., Maves L., Tapscott S.J. Conversion of MyoD to a neurogenic factor: binding site specificity determines lineage. Cell Rep. 2015, 10:1937-1946.
27. Gamble M.J., Kraus W.L. Multiple facets of the unique histone variant macroH2A: from genomics to cell biology. Cell Cycle 2010, 9:2568-2574.
28. Gamble M.J., Frizzell K.M., Yang C., Krishnakumar R., Kraus W.L. The histone variant macroH2A1 marks repressed autosomal chromatin, but protects a subset of its target genes from silencing. Genes Dev. 2010, 24:21-32.
29. Gaspar-Maia A., Qadeer Z.A., Hasson D., Ratnakumar K., Leu N.A., Leroy G., Liu S., Costanzi C., Valle-Garcia D., Schaniel C., et al. MacroH2A histone variants act as a barrier upon reprogramming towards pluripotency. Nat. Commun. 2013, 4:1565.
30. Gerber A.N., Klesert T.R., Bergstrom D.A., Tapscott S.J. Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis. Genes Dev. 1997, 11:436-450.
31. Heintzman N.D., Hon G.C., Hawkins R.D., Kheradpour P., Stark A., Harp L.F., Ye Z., Lee L.K., Stuart R.K., Ching C.W., et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009, 459:108-112.
32. Heinz S., Benner C., Spann N., Bertolino E., Lin Y.C., Laslo P., Cheng J.X., Murre C., Singh H., Glass C.K. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 2010, 38:576-589.
33. Huang W., Sherman B.T., Lempicki R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009, 37:1-13.
34. Huang W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
35. Hussey K.M., Chen H., Yang C., Park E., Hah N., Erdjument-Bromage H., Tempst P., Gamble M.J., Kraus W.L. The histone variant MacroH2A1 regulates target gene expression in part by recruiting the transcriptional coregulator PELP1. Mol. Cell. Biol. 2014, 34:2437-2449.
36. Iwafuchi-Doi M., Zaret K.S. Pioneer transcription factors in cell reprogramming. Genes Dev. 2014, 28:2679-2692.
37. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080.
38. Jin C., Felsenfeld G. Nucleosome stability mediated by histone variants H3.3 and H2A.Z. Genes Dev. 2007, 21:1519-1529.
39. Jin C., Zang C., Wei G., Cui K., Peng W., Zhao K., Felsenfeld G. H3.3/H2A.Z double variant-containing nucleosomes mark 'nucleosome-free regions' of active promoters and other regulatory regions. Nat. Genet. 2009, 41:941-945.
40. Kapoor A., Goldberg M.S., Cumberland L.K., Ratnakumar K., Segura M.F., Emanuel P.O., Menendez S., Vardabasso C., Leroy G., Vidal C.I., et al. The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature 2010, 468:1105-1109.
41. Kundaje A., Meuleman W., Ernst J., Bilenky M., Yen A., Heravi-Moussavi A., Kheradpour P., Zhang Z., Wang J., Ziller M.J., et al. Integrative analysis of 111 reference human epigenomes. Nature 2015, 518:317-330. Roadmap Epigenomics Consortium.
42. Kustatscher G., Hothorn M., Pugieux C., Scheffzek K., Ladurner A.G. Splicing regulates NAD metabolite binding to histone macroH2A. Nat. Struct. Mol. Biol. 2005, 12:624-625.
43. Ladurner A.G. Inactivating chromosomes: a macro domain that minimizes transcription. Mol. Cell 2003, 12:1-3.
44. Langmead B., Trapnell C., Pop M., Salzberg S.L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009, 10:R25.
45. Magnani L., Ballantyne E.B., Zhang X., Lupien M. PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer. PLoS Genet. 2011, 7:e1002368.
46. Maves L., Waskiewicz A.J., Paul B., Cao Y., Tyler A., Moens C.B., Tapscott S.J. Pbx homeodomain proteins direct Myod activity to promote fast-muscle differentiation. Development 2007, 134:3371-3382.
47. Maze I., Noh K.M., Soshnev A.A., Allis C.D. Every amino acid matters: essential contributions of histone variants to mammalian development and disease. Nat. Rev. Genet. 2014, 15:259-271.
48. Métivier R., Penot G., Hübner M.R., Reid G., Brand H., Kos M., Gannon F. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003, 115:751-763.
49. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstråle M., Laurila E., et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003, 34:267-273.
50. Mousavi K., Zare H., Wang A.H., Sartorelli V. Polycomb protein Ezh1 promotes RNA polymerase II elongation. Mol. Cell 2012, 45:255-262.
51. Mousavi K., Zare H., Dell'orso S., Grontved L., Gutierrez-Cruz G., Derfoul A., Hager G.L., Sartorelli V. eRNAs promote transcription by establishing chromatin accessibility at defined genomic loci. Mol. Cell 2013, 51:606-617.
52. Pasque V., Gillich A., Garrett N., Gurdon J.B. Histone variant macroH2A confers resistance to nuclear reprogramming. EMBO J. 2011, 30:2373-2387.
53. Pehrson J.R., Fried V.A. MacroH2A, a core histone containing a large nonhistone region. Science 1992, 257:1398-1400.
54. Podrini C., Koffas A., Chokshi S., Vinciguerra M., Lelliott C.J., White J.K., Adissu H.A., Williams R., Greco A. MacroH2A1 isoforms are associated with epigenetic markers for activation of lipogenic genes in fat-induced steatosis. FASEB J. 2014, 29:1676-1687.
55. Quinlan A.R., Hall I.M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 2010, 26:841-842.
56. Rada-Iglesias A., Bajpai R., Swigut T., Brugmann S.A., Flynn R.A., Wysocka J. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 2011, 470:279-283.
57. Ramakrishnan V., Finch J.T., Graziano V., Lee P.L., Sweet R.M. Crystal structure of globular domain of histone H5 and its implications for nucleosome binding. Nature 1993, 362:219-223.
58. Rasmussen T.P., Huang T., Mastrangelo M.A., Loring J., Panning B., Jaenisch R. Messenger RNAs encoding mouse histone macroH2A1 isoforms are expressed at similar levels in male and female cells and result from alternative splicing. Nucleic Acids Res. 1999, 27:3685-3689.
59. Ratnakumar K., Duarte L.F., LeRoy G., Hasson D., Smeets D., Vardabasso C., Bönisch C., Zeng T., Xiang B., Zhang D.Y., et al. ATRX-mediated chromatin association of histone variant macroH2A1 regulates α-globin expression. Genes Dev. 2012, 26:433-438.
60. Skene P.J., Henikoff S. Histone variants in pluripotency and disease. Development 2013, 140:2513-2524.
61. Soufi A., Garcia M.F., Jaroszewicz A., Osman N., Pellegrini M., Zaret K.S. Pioneer transcription factors target partial DNA motifs on nucleosomes to initiate reprogramming. Cell 2015, 161:555-568.
62. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 2005, 102:15545-15550.
63. Tapscott S.J. The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development 2005, 132:2685-2695.
64. Trapnell C., Pachter L., Salzberg S.L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009, 25:1105-1111.
65. Trapnell C., Hendrickson D.G., Sauvageau M., Goff L., Rinn J.L., Pachter L. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat. Biotechnol. 2013, 31:46-53.
66. Whyte W.A., Orlando D.A., Hnisz D., Abraham B.J., Lin C.Y., Kagey M.H., Rahl P.B., Lee T.I., Young R.A. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 2013, 153:307-319.
67. Yaffe D., Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1977, 270:725-727.
68. Zang C., Schones D.E., Zeng C., Cui K., Zhao K., Peng W. A clustering approach for identification of enriched domains from histone modification ChIP-Seq data. Bioinformatics 2009, 25:1952-1958.
69. Zaret K.S., Carroll J.S. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 2011, 25:2227-2241.
70. Zentner G.E., Tesar P.J., Scacheri P.C. Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions. Genome Res. 2011, 21:1273-1283.
71. Zhang Y., Liu T., Meyer C.A., Eeckhoute J., Johnson D.S., Bernstein B.E., Nusbaum C., Myers R.M., Brown M., Li W., Liu X.S. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008, 9:R137.